首页> 美国卫生研究院文献>Infection and Immunity >Haemophilus influenzae Porin Induces Toll-Like Receptor 2-Mediated Cytokine Production in Human Monocytes and Mouse Macrophages
【2h】

Haemophilus influenzae Porin Induces Toll-Like Receptor 2-Mediated Cytokine Production in Human Monocytes and Mouse Macrophages

机译:流感嗜血杆菌Porin诱导人单核细胞和小鼠巨噬细胞中Toll样受体2介导的细胞因子产生。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The production of proinflammatory cytokines is likely to play a major pathophysiological role in meningitis and other infections caused by Haemophilus influenzae type b (Hib). Previous studies have shown that Hib porin contributes to signaling of the inflammatory cascade. We examined here the role of Toll-like receptors (TLRs) and the TLR-associated adaptor protein MyD88 in Hib porin-induced production of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6). Hib porin-induced TNF-α and IL-6 production was virtually eliminated in macrophages from TLR2- or MyD88-deficient mice. In contrast, macrophages from lipopolysaccharide (LPS)-hyporesponsive C3H/HeJ mice, which are defective in TLR4 function, responded normally to Hib porin. Moreover anti-TLR2 antibodies but not anti-TLR4 antibodies significantly reduced Hib porin-stimulated TNF-α and IL-6 release from the human monocytic cell line THP-1. These data indicate that the TLR2/MyD88 pathway plays an essential role in Hib porin-mediated cytokine production. These findings may be useful in the development of alternative therapies aimed at reducing excessive inflammatory responses during Hib infections.
机译:促炎细胞因子的产生可能在由b型流感嗜血杆菌(Hib)引起的脑膜炎和其他感染中起主要的病理生理作用。先前的研究表明,Hib孔蛋白有助于发炎性级联反应。我们在这里检查了Toll样受体(TLR)和TLR相关的衔接蛋白MyD88在Hib孔蛋白诱导的肿瘤坏死因子α(TNF-α)和白介素6(IL-6)产生中的作用。在TLR2或MyD88缺陷型小鼠的巨噬细胞中,Hib孔蛋白诱导的TNF-α和IL-6的产生实际上被消除了。相比之下,TLR4功能缺陷的脂多糖(LPS)低反应性C3H / HeJ小鼠巨噬细胞通常对Hib孔蛋白有反应。此外,抗TLR2抗体而非抗TLR4抗体显着降低了Hib孔蛋白刺激的人单核细胞系THP-1的TNF-α和IL-6释放。这些数据表明TLR2 / MyD88途径在Hib孔蛋白介导的细胞因子产生中起重要作用。这些发现可能对开发旨在减少Hib感染期间过度的炎症反应的替代疗法有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号